Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer von Sparano, Joseph A, Gray, Robert J, Makower, Della F, Pritchard, Kathleen I, Albain, Kathy S, Hayes, Daniel F, Geyer, Charles E, Dees, Elizabeth C, Goetz, Matthew P, Olson, John A, Lively, Tracy, Badve, Sunil S, Saphner, Thomas J, Wagner, Lynne I, Whelan, Timothy J, Ellis, Matthew J, Paik, Soonmyung, Wood, William C, Ravdin, Peter M, Keane, Maccon M, Gomez Moreno, Henry L, Reddy, Pavan S, Goggins, Timothy F, Mayer, Ingrid A, Brufsky, Adam M, Toppmeyer, Deborah L, Kaklamani, Virginia G, Berenberg, Jeffrey L, Abrams, Jeffrey, Sledge, George W

Volltext

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer von Sparano, Joseph A, Gray, Robert J, Makower, Della F, Pritchard, Kathleen I, Albain, Kathy S, Hayes, Daniel F, Geyer, Charles E, Dees, Elizabeth C, Perez, Edith A, Olson, John A, Zujewski, JoAnne, Lively, Tracy, Badve, Sunil S, Saphner, Thomas J, Wagner, Lynne I, Whelan, Timothy J, Ellis, Matthew J, Paik, Soonmyung, Wood, William C, Ravdin, Peter, Keane, Maccon M, Gomez Moreno, Henry L, Reddy, Pavan S, Goggins, Timothy F, Mayer, Ingrid A, Brufsky, Adam M, Toppmeyer, Deborah L, Kaklamani, Virginia G, Atkins, James N, Berenberg, Jeffrey L, Sledge, George W

Volltext

Phase II study of 5‐fluorouracil and folinic acid in the treatment of patients with advanced gastric cancer. A southwest oncology group study von Berenberg, Jeffrey L., Tangen, Catherine, Macdonald, John S., Hutchins, Laura F., Natale, Ronald B., Oishi, Noboru, Guy, Jerry T., Fleming, Thomas R.

Volltext

A phase II evaluation of ifosfamide and mesna in unresectable diffuse malignant mesothelioma: A southwest oncology group study von Zidar, Bernard L., Metch, Barbara, Balcerzak, Stanley P., Pierce, H. Irving, Militello, Liboria, Keppen, Michael D., Berenberg, Jeffrey L.

Volltext

Adjuvant chemotherapy with 5-FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A Southwest Oncology Group study von Macdonald, J S, Fleming, T R, Peterson, R F, Berenberg, J L, McClure, S, Chapman, R A, Eyre, H J, Solanki, D, Cruz, Jr, A B, Gagliano, R

Volltext

Response to treatment of breast cancer von BERENBERG, J. L

Volltext

Abstract GS4-07: Race, ethnicity and clinical outcomes in hormone receptor-positive, HER2-negative, node-negative breast cancer: results from the TAILORx trial von Albain, K, Gray, RJ, Sparano, JA, Makower, DF, Pritchard, KI, Hayes, DF, Geyer, CE, Dees, EC, Goetz, MP, Olson, JA, Lively, T, Badve, SS, Saphner, TJ, Wagner, LI, Whelan, TJ, Ellis, MJ, Paik, S, Wood, WC, Ravdin, PM, Keane, MM, Gomez, HL, Reddy, PS, Goggins, TF, Mayer, IA, Brufsky, AM, Toppmeyer, DL, Kaklamani, VG, Berenberg, JL, Abrams, J, Sledge, GW

Volltext

VM-26 in gastric cancer : a southwest oncology group study von BERENBERG, J. L, TANGEN, C, MACDONALD, J. S, BARLOGIE, B, LAUFMAN, L. R

Volltext

Evaluation of a urea/lactic acid-based topical keratolytic agent (ULABTKA) for prevention of capecitabine-induced hand and foot syndrome (HFS): NCCTG trial N05C5 von Wolf, S. L., Qin, R., Menon, S. P., Rowland, K. M., Kugler, J. W., Flynn, P. J., Christian, D., Satele, D., Berenberg, J. L., Loprinzi, C. L.

Volltext

Primary liver cancer in a referral hospital in Hawaii von Geer, Deborah A., Lee, Yeu-Tsu Margaret, Brooks, Viola P., Berenberg III, Jeffery L.

Volltext

Chemotactic factor inactivator in normal human serum von Berenberg, J L, Ward, P A

Volltext

Abstract P2-08-01: Prospective trial of endocrine therapy alone in patients with estrogen receptor positive, HER2-negative, node-negative breast cancer: Results of the TAILORx low... von Sparano, JA, Gray, RJ, Makower, DF, Pritchard, KI, Albain, KS, Hayes, DF, Geyer, CE, Dees, EC, Perez, EA, Olson, JA, Zujweski, J, Keane, MM, Gomez Moreno, HL, Reddi, RP, Goggins, TF, Mayer, IA, Brufsky, AM, Toppmeyer, DL, Kaklamani, VG, Atkins, JN, Berenberg, JL, Sledge, GW

Volltext

Efficacy of cancer risk assessment (CRA) through teleconferencing von Berenberg, J. L., Rasmussen, T., Cina, C., Chung, M., Davis, J., Donlon, S.

Volltext

Therapy of refractory adult acute lymphoblastic leukemia with vincristine and prednisone plus tandem methotrexate and L-asparaginase: results of a cancer and leukemia group B study von TEREBELO, H. R, ANDERSON, K, WIERNIK, P. H, CUTTNER, J, COOPER, R. M, FASO, L, BERENBERG, J. L

Volltext

Tick-Bite Injury: Mediation by a Complement-Derived Chemotictic Chemotactic Factor von Berenberg, J. L, Ward, P. A, Sonenshine, D. E

Volltext

Treatment of advanced colorectal carcinoma with 5-fluorouracil, leucovorin and Roferon-A®: a southwest oncology study group study von ERNEST MARSHALL, M, TANGEN, C. M, BERENBERG, J. L, BALCERZAK, S. P, BROWN, T, MACDONALD, J. S

Volltext

Progressive warfarin anticoagulation in protein C deficiency: A therapeutic strategy von Enzenauer, Raymond J., Berenberg, Jeffrey L., Campbell, Janice

Volltext

Difficult Diagnostic Cases: CASE 3. Oncogenic Osteomalacia Associated With Hemangiopericytoma Localized by Octreotide Scan von Auethavekiat, Paranee, Roberts, Jefferson R., Biega, Timothy J., Toney, Morakinyo O., Christensen, Reed S., Belnap, Christina M., Berenberg, Jeffrey L.

Volltext

Microangiopathic hemolytic anemia as the initial manifestation of porcine valve failure von Enzenauer, R J, Berenberg, J L, Cassell, Jr, P F

Volltext

Phase II study of 5‐fluorouracil and folinic acid in the treatment of patients with advanced gastric cancer: A Southwest Oncology Group study von Colucci, Giuseppe

Volltext